跳至主要内容
临床试验/RPCEC00000227
RPCEC00000227尚未招募4 期

Median term study of the effects of Policosanol in patients with metabolic syndrome and ischaemic cardiopathy - Poli/Pla-SM-CI

Center of Natural Products, National Center for Scientific Research0 个研究点目标入组 100 人开始时间: 2016年12月27日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
25 years 至 70 years(—)
性别
All

入选标准

  • 1) Patients with ischaemic cardiopaty.
  • 2) Both sexes.
  • 3) Age: 25-70 years
  • 4) Diagnostic of metabolic syndrome by NCEP-ATP III criteria

排除标准

  • 1) Consuming policosanol or other lipid lowering drug and antioxidant or pro-oxidant medications, six months period previus study.
  • 2) Ischaemic or haemorragic ictus.
  • 3) Mayor surgery six mionths previusat study begining.
  • 4) Cardiac insuficience.
  • 5) Hepatic insuficience.
  • 6) Neoplasms diagnosed.
  • 7) Alcoholism.
  • 8) Psyquiatric problems.
  • 9) Patients with clinical history of allergy to any other medicines or other conditions that endanger their health and their lives during the study.

研究者

发起方
Center of Natural Products, National Center for Scientific Research

相似试验